167 related articles for article (PubMed ID: 10461547)
1. The role of CYP2B6 in human xenobiotic metabolism.
Ekins S; Wrighton SA
Drug Metab Rev; 1999 Aug; 31(3):719-54. PubMed ID: 10461547
[No Abstract] [Full Text] [Related]
2. [Cloning of the human cytochrome p450 2B6 gene in Escherichia coli cells].
Kolomeĭchuk SN; Pokrovskaia MV; Borisova AA; Zhgun AA; Solodar' LI; Sokolov NN; Shvets VI; Gervaziev IuV; El'darov MA; Archakov AI
Vopr Med Khim; 2001; 47(6):609-19. PubMed ID: 11925752
[TBL] [Abstract][Full Text] [Related]
3. Combined three-dimensional quantitative structure-activity relationship analysis of cytochrome P450 2B6 substrates and protein homology modeling.
Wang Q; Halpert JR
Drug Metab Dispos; 2002 Jan; 30(1):86-95. PubMed ID: 11744616
[TBL] [Abstract][Full Text] [Related]
4. Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme-substrate interactions.
Lewis DF; Lake BG; Dickins M; Goldfarb PS
Drug Metabol Drug Interact; 2002; 19(2):115-35. PubMed ID: 12751910
[TBL] [Abstract][Full Text] [Related]
5. Editorial: in this issue.
Prakash C
Curr Drug Metab; 2008 Jun; 9(5):361-2. PubMed ID: 18537572
[No Abstract] [Full Text] [Related]
6. Further characterization of the expression in liver and catalytic activity of CYP2B6.
Ekins S; Vandenbranden M; Ring BJ; Gillespie JS; Yang TJ; Gelboin HV; Wrighton SA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1253-9. PubMed ID: 9732386
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of CYP expression in hepatoma cells stably transfected by chimeric nuclear receptors.
Küblbeck J; Reinisalo M; Mustonen R; Honkakoski P
Eur J Pharm Sci; 2010 Jul; 40(4):263-72. PubMed ID: 20381613
[TBL] [Abstract][Full Text] [Related]
8. Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes.
Granvil CP; Madan A; Sharkawi M; Parkinson A; Wainer IW
Drug Metab Dispos; 1999 Apr; 27(4):533-41. PubMed ID: 10101149
[TBL] [Abstract][Full Text] [Related]
9. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ
Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407
[TBL] [Abstract][Full Text] [Related]
10. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes.
Yamazaki H; Shimada T
Xenobiotica; 1999 Mar; 29(3):231-41. PubMed ID: 10219964
[TBL] [Abstract][Full Text] [Related]
11. Detection of single nucleotide polymorphisms in CYP2B6 gene.
Zanger UM; Fischer J; Klein K; Lang T
Methods Enzymol; 2002; 357():45-53. PubMed ID: 12424896
[No Abstract] [Full Text] [Related]
12. Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4.
Lewis DF; Lake BG; Dickins M; Eddershaw PJ; Tarbit MH; Goldfarb PS
Xenobiotica; 1999 Apr; 29(4):361-93. PubMed ID: 10375007
[TBL] [Abstract][Full Text] [Related]
13. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes.
Hijazi Y; Boulieu R
Drug Metab Dispos; 2002 Jul; 30(7):853-8. PubMed ID: 12065445
[TBL] [Abstract][Full Text] [Related]
14. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
Ramírez J; Innocenti F; Schuetz EG; Flockhart DA; Relling MV; Santucci R; Ratain MJ
Drug Metab Dispos; 2004 Sep; 32(9):930-6. PubMed ID: 15319333
[TBL] [Abstract][Full Text] [Related]
15. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.
Faucette SR; Hawke RL; Lecluyse EL; Shord SS; Yan B; Laethem RM; Lindley CM
Drug Metab Dispos; 2000 Oct; 28(10):1222-30. PubMed ID: 10997944
[TBL] [Abstract][Full Text] [Related]
16. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite.
Kazui M; Nishiya Y; Ishizuka T; Hagihara K; Farid NA; Okazaki O; Ikeda T; Kurihara A
Drug Metab Dispos; 2010 Jan; 38(1):92-9. PubMed ID: 19812348
[TBL] [Abstract][Full Text] [Related]
17. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
Heyn H; White RB; Stevens JC
Drug Metab Dispos; 1996 Sep; 24(9):948-54. PubMed ID: 8886603
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of human cytochrome P-450 2B6 using a novel substrate, site-directed mutagenesis, and molecular modeling.
Domanski TL; Schultz KM; Roussel F; Stevens JC; Halpert JR
J Pharmacol Exp Ther; 1999 Sep; 290(3):1141-7. PubMed ID: 10454488
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.
Hamaoka N; Oda Y; Hase I; Asada A
Br J Anaesth; 2001 Apr; 86(4):540-4. PubMed ID: 11573629
[TBL] [Abstract][Full Text] [Related]
20. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Hesse LM; Venkatakrishnan K; Court MH; von Moltke LL; Duan SX; Shader RI; Greenblatt DJ
Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
